Arcadia Biosciences raises $6.8M to fund hemp opportunities, cushion from coronavirus

Proactive Investors

View Source

Arcadia Biosciences’ CEO Matt Plavan tells Proactive that the agricultural technology company has raised about $6.8 million by selling warrants. Plavan says the company expects to use the proceeds to pursue a range of near-term inorganic growth opportunities within its hemp business unit as well as a cushion from coronavirus. Plavan also discussed its most recent quarterly earnings.